Kezar Life Sciences Inc (KZR)
NASDAQ:KZR

Kezar Life Sciences (KZR) Stock Forecast & Price Target

276 Followers
See the Price Targets and Ratings of:

KZR Analyst Ratings

Moderate Buy
1Ratings
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Kezar
Life Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KZR Stock 12 Months Forecast

Average Price Target

$21.00
▲(183.78% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Kezar Life Sciences in the last 3 months. The average price target is $21.00 with a high forecast of $21.00 and a low forecast of $21.00. The average price target represents a 183.78% change from the last price of $7.40.
Highest Price Target$21.00Average Price Target$21.00Lowest Price Target$21.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
William Blair
Buy
Reiterated
Jefferies
$20.00
Buy
170.27%
Upside
Reiterated
Analysts Offer Insights on Healthcare Companies: Pfizer (NYSE: PFE), Fate Therapeutics (NASDAQ: FATE) and Kezar Life Sciences (NASDAQ: KZR)
Wells Fargo
$17.00
Buy
129.73%
Upside
Reiterated
Analysts' Opinions Are Mixed on These Healthcare Stocks: Novo Nordisk (NYSE: NVO) and Kezar Life Sciences (NASDAQ: KZR)
JonesTrading
$20.00
Buy
170.27%
Upside
Reiterated
Kezar Life Sciences price target raised to $20 from $17 at JonesTradingKezar Life Sciences price target raised to $20 from $17 at JonesTrading
Cowen & Co.
Buy
Reiterated
Cowen & Co. Reiterates Outperform on Kezar Life Sciences Shares
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

KZR Financial Forecast

KZR Earnings Forecast
Next quarter’s earnings estimate for KZR is -$0.28 with a range of -$0.29 to -$0.24. The previous quarter’s EPS was -$0.25. KZR beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.51% of the time in the same period. In the last calendar year KZR has Outperformed its overall industry.
Next quarter’s earnings estimate for KZR is -$0.28 with a range of -$0.29 to -$0.24. The previous quarter’s EPS was -$0.25. KZR beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.51% of the time in the same period. In the last calendar year KZR has Outperformed its overall industry.
No data currently available
KZR Sales Forecast
Next quarter’s sales forecast for KZR is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. KZR beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 42.84% of the time in the same period. In the last calendar year KZR has Underperformed its overall industry.
Next quarter’s sales forecast for KZR is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. KZR beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 42.84% of the time in the same period. In the last calendar year KZR has Underperformed its overall industry.
KZR Analyst Recommendation Trends
In the current month, KZR has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KZR average analyst price target in the past 3 months is $21.00
In the current month, KZR has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KZR average analyst price target in the past 3 months is $21.00

KZR Stock Forecast FAQ

What is KZR’s average 12-month price target, according to analysts?
Based on analyst ratings, Kezar Life Sciences’s 12-month average price target is $21.00.
    What is KZR’s upside potential, based on the analysts’ average price target?
    Kezar Life Sciences has 183.78% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is KZR a Buy, Sell or Hold?
          Kezar Life Sciences has a conensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Kezar Life Sciences’s price target?
            The average price target for Kezar Life Sciences is $21.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $21.00 ,the lowest forecast is $21.00. The average price target represents 183.78% Increase from the current price of $7.4.
              What do analysts say about Kezar Life Sciences?
              Kezar Life Sciences’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis